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Abstract
Background: The aim of this study was to identify the relationships between borderline serum liver enzyme
abnormalities and the incidence of impaired fasting glucose (IFG) and diabetes mellitus (DM) during a 7-year
follow-up of workers, and to evaluate the quantitative level of risks.
Methods: A total of 749 workers in an electronics manufacturing company were divided into the normal fasting
blood glucose (n = 633), IFG (n = 98), and DM (n = 18) groups, according to the results of their health checkup in
2006. Among 633 workers in the normal group, excluding 55 workers who were impossible to follow, incidence
rate and relative risks of 578 workers to the IFG or DM in 2013 according to the levels of aspartate aminotransferase
(AST), alanine aminotransferase (ALT), and gamma-glutamyltransferase (γ-GTP) were investigated. The liver enzyme
levels were categorized as A (normal), B (borderline elevation), and R (definite elevation) following the standard of
the National Health Insurance Service of Korea.
Results: The incidence rate of IFG or DM based on ALT level was 9.7 % for the A, 30.0 % for B, and 15.4 % for R. According
to γ-GTP, the incidence rate was 9.8 % for A, 34.5 % for B, and 25.0 % for R. The relative risk(RR) to the incidence of IFG or
DM depending on the level of ALT were 3.09 in B and 1.59 in R compared to A. According to γ-GTP, RR was 3.52 in B and
2.55 in R compared to A. AST level was not related to the incidence of IFG or DM. A multiple logistic regression analysis
with the incidence of IFG or DM as a dependent variable resulted in an odds ratio of 2.664(1.214–5.849) for B level ALT,
3.685(1.405–9.667) for B level of γ-GTP even after adjustment for other variables such as age, sex, body mass index, AUDIT
score, systolic blood pressure, and triglyceride.
Conclusions: Even borderline elevations of ALT and γ-GTP, but not AST, increased the incidence and risk of IFG or DM
after 7 years. Borderline elevation of ALT and γ-GTP was identified as an independent risk factor of IFG or DM.
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Background
Diabetes mellitus (DM) is a main risk factor of cerebro-
cardiovascular diseases along with hypertension and hyper-
lipidemia, and its incidence tends to rapidly increase [1].
According to the report of the World Health Organization,
the total number of people with DM is projected to rise
from 171 million in 2000 to 366 million in 2030 [2]. In
Korea, the DM prevalence rate was estimated to be <1 %
of the population in the 1970s. In 2003, there were a total
of 2,694,220 DM patients between 20 and 79 years old, ac-
counting for 7.75 % of the total population, and new pa-
tients corresponding to 10 % of the total DM patients are
additionally found every year [3].
Serum liver enzymes, including aspartate aminotransfer-
ase (AST), alanine aminotransferase (ALT), and gamma-
glutamyltransferase (γ-GTP), are indices of liver dysfunc-
tion. In particular, γ-GTP has been used as a clinical and
epidemiological index of hepatobiliary diseases and alco-
hol intake [4]. γ-GTP has been reported to have a strong
relation with obesity and fatty liver, and to contribute to
insulin resistance [5]. According to multiple previous
studies, it was turned out that γ-GTP playing an import-
ant intracellular antioxidant role by maintaining a high
glutathione concentration. Therefore, it was suggested to
be a potential biomarker of oxidative stress [6–8]. AST,
ALT and γ-GTP is three major enzyme that have been in-
cluded in periodic health checkup in working population
in Korea. Increases in the serum liver enzyme levels may
indicative of beginning of the development of life style re-
lated disease in young workers. However, its seriousness is
often not recognized because of the absence of symptoms.
If when worker’s liver enzyme levels were high enough, it
is fully expected that possibility of hepatobiliary diseases
or other life style related disease is high. But when the ab-
normality level is minimal, it is usually neglected by
workers themselves and also by occupational health man-
ager. Therefore, it is necessary to accumulate scientific ev-
idences showing that even mild increase of serum liver
enzymes is a indicative signal of diseases caused by the ac-
cumulation of unhealthy life habits, and that it would pro-
gress to chronic disease such as DM unless the health
related life habits are improved.
Multiple studies revealed that serum γ-GTP was an in-
dependent risk factor that could predict the incidences
of type 2 DM and impaired fasting glucose (IFG) [9–12].
Elevation of γ-GTP was related to cardiovascular disease
and metabolic syndrome [13, 14]. Serum ALT also was
shown to be a factor that predicted DM incidence in
some prospective studies [15–18], and ALT concentra-
tion was reported to be a useful index for predicting
metabolic syndrome [19]. Although there have been
many studies on the relationships between liver enzymes
and IFG and DM, scientific evidence about amount of
effect of borderline abnormality of liver enzyme is still
lacking. Therefore, it is necessary to conduct a study that
can directly helpful in the health management of workers,
based on the abnormality of serum liver enzymes in work-
ing population. Especially, we want to know how much
risks can borderline liver enzyme abnormalities increase
to the occurrence of IFG or DM.
The purpose of this study was to identify the relation-
ships between serum liver enzyme levels and the inci-
dences of IFG and DM during a 7-year follow-up of
workers, and to evaluate the quantitative level of risks in
borderline elevation of liver enzyme levels.
Methods
The research subjects were 749 workers in an electronics
manufacturing company located in Korea. The workers
were divided into the normal, IFG, and DM group ac-
cording to their fasting blood glucose levels and present
medical history based on health checkup results in 2006.
There were 633(84.5 %) workers in the normal, 98(13.1 %)
in the IFG, and 18(2.4 %) in the DM group. Then, among
the 633 normal group workers, new development of IFG or
DM based on the health checkup results in 2013 were in-
vestigated in 578 workers, excluding 55 workers who were
impossible to follow because of resignation, maternity leave,
or a long-term business trip (Fig. 1).
The health checkup was done following the regulation
of the National Health Insurance Service (NHIS) of
Korea, in the same hospital in the year of 2006 and
2013. All workers were asked to agree to the academic
use of the health checkup results by filling out a consent
form. Disease history and health related behaviors were sur-
veyed by using the self-administered health risk assessment
survey form used in the NHIS of Korea. Concerning smok-
ing status, the workers were categorized as non-smokers
group, ex-smokers group or current smokers group. Alco-
hol drinking was investigated by using the AUDIT-K [20],
in which the unhealthy alcohol drinking group was defined
as workers with a score of ≥10 points for males and ≥8
points for females, of a total of 40 points in AUDIT-K. The
workers were also divided according to weekly number of
exercise: no exercise, one to two times per week, or three
times or more per week. Occupations were divided into of-
fice work, production work, and research work, and job po-
sitions were divided into executive position and general
position. Blood test was performed after fasting for >8 h, in
which hemoglobin, fasting blood glucose, AST, ALT, γ-
GTP, total cholesterol, triglyceride, and High density lipo-
protein cholesterol (HDL-C) were measured.
According to the criteria of DM diagnosis by the
American Diabetes Association in 2014 [21], a normal blood
glucose level was defined as a value of <100 mg/dL after 8 h
of fasting, IFG as 100 to <126 mg/dL, and DM as ≥126 mg/
dL. If subjects had medical history of DM, they were classi-
fied as DM even if their blood glucose level were lower than
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125 mg/dL. Since there were only 4 new cases of DM in the
health checkup in 2013, all workers in the IFG and the DM
group were together defined as ‘IFG or DM’ as dependent
variable.
The levels of serum liver enzymes were categorized as A
(normal), B (borderline elevation), and R (definite eleva-
tion) following the standard of the NHIS of Korea [22].
Grade A was defined as ≤40 IU/L for AST, ≤35 IU/L for
ALT, or ≤63 IU/L in males or ≤35 IU/L in females for γ-
GTP. On the other hand, B was defined as 41–50 IU/L for
AST, 36–45 IU/L for ALT, and 64–77 IU/L in males or
36–45 IU/L in females for γ-GTP. R was defined as ≥51
IU/L for AST, ≥46 IU/L for ALT, and ≥78 IU/L in males
or ≥46 IU/L in females for γ-GTP. When serum liver en-
zymes were considered as dichotomous variables, the
values were classified as normal for A and abnormal for
both B and R.
The baseline demographic characteristics, health related
behaviors, and laboratory test results of the normal, IFG,
and DM group were cross-sectionally compared using the
chi-square test and ANOVA test. The characteristics be-
tween the group that maintained a normal fasting blood
glucose level and the group with IFG or DM after 7 years
were compared by using the chi-square test and ANOVA
test. The incidence rate and relative risks to IFG or DM
after 7 years depending on the initial serum liver enzyme
levels were calculated and compared by using the chi-
square test. To analyze the effects of elevated serum liver
enzymes, after the adjustment for other variables, multiple
logistic regression analysis was performed. Statistical ana-
lysis was performed by using SPSS version 14 (SPSS, Inc.,
Chicago, IL, USA).
Results
The characteristics of 633(84.5 %) workers in initial nor-
mal fasting blood glucose group, 98(13.1 %) in the IFG
group, and 18(2.4 %) in the DM group were compared.
The percentage IFG and the DM in the male was 16.9 %,
which was higher than 2.8 % in the female. The workers’
age was 38.9 ± 7.95 years for the normal, 45.4 ± 7.79 years
for the IFG, and 47.0 ± 8.68 years for the DM group.
Length of work history was 9.2 ± 7.67 years for the nor-
mal, 15.1 ± 8.43 years for the IFG and 15.8 ± 6.41 years for
DM group, showing that the group with high blood glu-
cose levels had an older age and a longer working history.
There was no difference depending on types of occupa-
tion. Executive workers had higher proportion of IFG and
DM than general workers. There were no differences in
alcohol drinking, smoking, exercise among the three
groups. Body mass index (BMI), systolic blood pressur-
e(BP), hemoglobin, AST, ALT, γ-GTP, total cholesterol,
and triglyceride, excluding diastolic BP and HDL-C,
showed unhealthier results in the group with a higher
blood glucose (p < 0.05) (Table 1).
The incidence of IFG or DM after 7 years in 578 initial
normal workers was 12.1 % (70 workers). There were no
differences in sex, age, work duration, type of occupa-
tion, job position, alcohol drinking, smoking, and exer-
cise between normal and IFG or DM group. There were
no differences in hemoglobin, AST, and total cholesterol,
whereas IFG or DM group showed unhealthier results in
BMI, systolic BP, diastolic BP, ALT, γ-GTP, triglyceride,
and HDL-C (p < 0.05) (Table 2).
When the incidence rate of IFG or DM after 7 years
were compared according to the levels of initial serum
Fig. 1 Study flow diagram. IFG, impaired fasting glucose; DM, diabetes mellitus
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liver enzymes, it was noted in 11.8 % with A level of AST,
in 20.0 % with B, and in 18.2 % with R, which were not sta-
tistically significant different. The incidence rates of IFG or
DM with A, B, and R levels of ALT resulted in 9.7, 30.0,
and 15.4 %, respectively, showing significant differences.
The incidence rates with A, B, and R levels of γ-GTP re-
sulted in 9.8, 34.5, and 25.0 %, respectively, showing signifi-
cant differences. When the incidence rates of IFG or DM
Table 1 Baseline characteristics of the study subjects according to initial serum fasting glucose level
Variables Normal IFG DM p-value*
n = 633 (84.5 %) n = 98 (13.1 %) n = 18 (2.4 %)
Demographic variables
Sexa 0.005
Male 561 (83.1) 97 (14.4) 17 (2.5)
Female 72 (97.3) 1 (1.4) 1 (1.4)
Age (year)b 38.9 ± 7.95 45.4 ± 7.79 47.0 ± 8.68 0.000
Work duration (year)b 9.2 ± 7.67 15.1 ± 8.43 15.8 ± 6.41 0.000
Occupationa 0.056
Office work 110 (79.1) 21 (15.1) 8 (5.8)
Production work 442 (85.8) 65 (12.6) 8 (1.6)
Research work 81 (85.3) 12 (12.6) 2 (2.1)
Job positiona 0.000
Executive 159 (70.4) 56 (24.8) 11 (4.9)
General 474 (90.6) 42 (8.0) 7 (1.3)
Health related behaviorsa
Alcohol drinking 0.989
Healthy drinking 393 (84.8) 60 (12.8) 11 (2.4)
Unhealthy drinking 235 (84.5) 36 (12.9) 7 (2.5)
Smoking 0.647
Non-smoker 308 (84.8) 49 (13.5) 6 (1.7)
Ex-smoker 81 (81.8) 14 (14.1) 4 (4.0)
Current smoker 240 (84.8) 35 (12.4) 8 (2.8)
Exercise per week 0.118
0 233 (86.9) 25 (9.3) 10 (3.7)
1-2 265 (82.8) 49 (15.3) 6 (1.9)
> 3 125 (85.6) 19 (13.0) 2 (1.4)
Laboratory test resultsb
BMI (kg/m2) 23.5 ± 2.95 24.6 ± 2.72 25.3 ± 2.98 0.000
Systolic BP (mmHg) 115.6 ± 11.15 123.4 ± 14.68 125.6 ± 11.74 0.000
Diastolic BP (mmHg) 70.8 ± 7.65 77.1 ± 11.39 76.3 ± 8.77 0.000
Hemoglobin (g/dL) 14.3 ± 1.37 14.6 ± 1.13 14.8 ± 1.23 0.032
AST (IU/L) 24.3 ± 8.81 25.9 ± 18.90 31.7 ± 28.47 0.015
ALT (IU/L) 26.7 ± 17.91 32.8 ± 30.00 46.4 ± 40.64 0.000
γ-GTP (IU/L) 36.2 ± 28.29 53.6 ± 45.80 67.4 ± 66.67 0.000
Total cholesterol (mg/dL) 188.9 ± 33.32 197.5 ± 36.59 221.7 ± 45.49 0.000
Triglyceride (mg/dL) 135.2 ± 98.86 162.3 ± 80.80 175.3 ± 107.62 0.018
HDL-C (mg/dL) 55.6 ± 12.37 52.0 ± 11.86 57.5 ± 15.67 0.032
IFG impaired fasting glucose, DM diabetes mellitus, BMI body mass index, BP blood pressure, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP
Gamma-glutamyltransferase, HDL High density lipoprotein
*Chi-square test or ANOVA test
aN (%)
bMean ± SD
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was compared depending on the number of abnormal
serum liver enzyme, 20.0 % was noted in the group with ab-
normal levels of one enzyme, 23.8 % with two enzymes,
and 33.3 % with three enzymes, which showed that a higher
number of abnormal serum liver enzymes resulted in a
higher incidence rate of IFG or DM. The relative risk (RR)
of ALT to the incidence of IFG or DM was 3.09 with the B,
and 1.59 with the R compared to the A level of ALT. The
RR of γ-GTP was 3.52 with the B, and 2.55 with the R com-
pared to the A level of γ-GTP. The RR was 2.27 with ab-
normal levels of one liver enzyme, 2.70 in two enzymes,
and 3.78 in three enzymes compared with the group with
no abnormal levels (p < 0.05) (Table 3).
A multiple logistic regression analysis was performed with
IFG or DM incidence as a dependent variable after adjusting
for the effects of other variables. For crude odds ratio(OR),
B level of ALT, B level of γ-GTP and R level of γ-GTP
showed significant OR of 3.981(2.020–7.846), 4.832(2.129–
10.964) and 3.060(1.413–6.628) respectively. Model 1, with
adjustment for age and sex, B level of ALT, B level of γ-GTP
and R level of γ-GTP showed an OR of 3.967(2.002–
7.860), 4.654(2.025–10.696) and 2.978(1.366–6.494) re-
spectively, showing a significantly higher risk. Model 2
with the addition of BMI to Model 1, B level of ALT
and B level of γ-GTP showed an OR of 3.002(1.471–
6.127) and 3.669(1.562–8.618) respectively, showing a
significantly higher risk. When risk was analyzed for
Model 3 with the addition of AUDIT score, systolic BP
and triglyceride to Model 2, B level of ALT and B level
of γ-GTP showed an OR of 2.664(1.214–5.849) and
3.685(1.405–9.667), respectively, showing a significantly
higher risk even after the adjustment for other vari-
ables, including age, sex, BMI, AUDIT score, systolic
BP, and triglyceride (Table 4).
Discussion
Among three serum liver enzymes, AST had no effect
on the incidence of IFG or DM after 7 years. Our results
are consistent with those reported by Nakanishi et al.
who found no association of AST with diabetes risk after
adjustment for other known risk factors in a study of male
Japanese office workers [23]. The groups with elevated
ALT and γ-GTP had high risks of IFG or DM incidence.
These findings are consistent with results of previous
studies on the relations of ALT and γ-GTP with the inci-
dences of IFG or DM. In a 2-year prospective study by
Cho et al., serum ALT was a factor predicting the inci-
dence of DM after adjustment for age, family history,
BMI, amount of alcohol drinking, and insulin resistance
[17]. Ohlson et al. reported that baseline ALT was a pre-
dictor of the incidence of type 2 diabetes after 13.5 years
of follow-up in a cohort of 766 Swedish males, with a sig-
nificant fourfold increased risk for males in the upper
quintile compared to the lowest quintile [24]. Vozarova
Table 2 Comparison of initial variables according to the blood
glucose level change over 7-years interval
Variables Staying normal IFG or DM p-value*
(n = 508, 87.9 %) (n = 70, 12.1 %)
Demographic variables
Sexa 0.534
Male 452 (87.6) 64 (12.4)
Female 56 (90.3) 6 (9.7)
Age (year)b 38.3 ± 7.89 39.5 ± 6.63 0.155
Work duration (year)b 8.7 ± 7.67 9.8 ± 6.97 0.252
Occupationa 0.343
Office work 87 (83.7) 17 (16.3)
Production work 350 (88.8) 44 (11.2)
Research work 71 (88.8) 9 (11.3)
Job positiona 0.925
Executive 126 (88.1) 17 (11.9)
General 382 (87.8) 53 (12.2)
Health related behaviorsa
Alcohol drinking 0.311
Healthy drinking 322 (89.0) 40 (11.0)
Unhealthy drinking 186 (86.1) 30 (13.9)
Smoking 0.304
Non-smoker 258 (89.9) 29 (10.1)
Ex-smoker 63 (87.5) 9 (12.5)
Current smoker 187 (85.4) 32 (14.6)
Exercise per week 0.995
0 185 (87.7) 26 (12.3)
1-2 214 (87.7) 30 (12.3)
≥ 3 103 (88.0) 14 (12.0)
Laboratory test resultsb
BMI (kg/m2) 23.3 ± 2.83 24.9 ± 3.34 0.000
Systolic BP (mmHg) 115.0 ± 11.07 120.2 ± 11.87 0.000
Diastolic BP (mmHg) 70.6 ± 7.74 73.6 ± 7.12 0.002
Hemoglobin (g/dL) 14.3 ± 1.33 14.5 ± 1.24 0.118
AST (IU/L) 24.0 ± 8.44 26.2 ± 11.77 0.125
ALT (IU/L) 26.0 ± 17.86 32.0 ± 19.29 0.009
γ-GTP (IU/L) 34.8 ± 27.06 44.3 ± 28.78 0.006
Total cholesterol
(mg/dL)
188.2 ± 33.82 194.0 ± 32.52 0.189
Triglyceride (mg/dL) 130.0 ± 90.60 156.8 ± 137.36 0.038
HDL-cholesterol
(mg/dL)
56.1 ± 12.58 52.1 ± 10.47 0.015
IFG impaired fasting glucose, DM diabetes mellitus, BMI body mass index, BP
blood pressure, AST aspartate aminotransferase, ALT alanine aminotransferase,
γ-GTP Gamma-glutamyltransferase, HDL High density lipoprotein
*Chi-square test or ANOVA test
aN (%)
bMean ± SD
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et al. found that higher ALT was a significant and inde-
pendent predictor of incident type 2 diabetes mellitus with
a two-fold increased risk, after adjustment for age, sex,
body fat, insulin sensitivity and acute insulin response
[18]. Although the mechanism underlying the associations
between ALT and incidence of DM remains unclear, some
possibilities can be considered. One is that increased
serum ALT levels reflect an excess deposit of fat in the
liver, a condition known as non-alcoholic fatty liver disease
(NAFLD) [25]. NAFLD, which is closely related to obesity
and visceral fat deposition, is now regarded as a feature of
insulin resistance syndrome [5], and visceral adipose tissue
is known to confer a significantly higher risk of type 2 dia-
betes [26]. Excess visceral fat accumulation may be causally
Table 3 Relative risks to the incidence of IFG or DM according to initial liver enzyme levels
Levels of initial liver enzyme Blood glucose level Relative
Risk
p-value*
Staying normal IFG or DM
AST (IU/L) 0.305
Aa 487 (88.2) 65 (11.8) 1
Bb 12 (80.0) 3 (20.0) 1.69
Rc 9 (81.8) 2 (18.2) 1.54
ALT (IU/L) 0.011
A 418 (90.3) 45 (9.7) 1
B 35 (70.0) 15 (30.0) 3.09
R 55 (84.6) 10 (15.4) 1.59
γ-GTP (IU/L) 0.000
A 459 (90.2) 50 (9.8) 1
B 19 (65.5) 10 (34.5) 3.52
R 30 (75.0) 10 (25.0) 2.55
Number of abnormal liver enzymes 0.000
0 396 (91.2) 38 (8.8) 1
1 72 (80.0) 18 (20.0) 2.27
2 32 (76.2) 10 (23.8) 2.70
3 8 (66.7) 4 (33.3) 3.78
IFG impaired fasting glucose, DM diabetes mellitus, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP gamma-glutamyltransferase
aA was defined as ≤40 IU/L for AST, ≤35 IU/L for ALT, or ≤63 IU/L in males or ≤35 IU/L in females for γ-GTP
bB was defined as 41–50 IU/L for AST, 36–45 IU/L for ALT, and 64–77 IU/L in males or 36–45 IU/L in females for γ-GTP
cR was defined as ≥51 IU/L for AST, ≥46 IU/L for ALT, and ≥78 IU/L in males or ≥46 IU/L in females for γ-GTP
*Chi-square test
Table 4 Adjusted odds ratio of initial liver enzyme categories for IFG or DM
Dependent variable = Incidence of IFG or DM
Crude Model 1 Model 2 Model 3
AST A 1 1 1 1
B 1.873(0.515–6.814) 1.776(0.486–6.491) 1.252(0.338–4.641) 1.477(0.380–5.737)
R 1.665(0.352–7.875) 1.685(0.355–8.001) 1.229(0.251–6.014) 1.120(0.215–5.836)
ALT A 1 1 1 1
B 3.981(2.020–7.846) 3.967(2.002–7.860) 3.002(1.471–6.127) 2.664(1.214–5.849)
R 1.689(0.805–3.542) 1.653(0.784–3.484) 1.060(0.476–2.356) 1.039(0.446–2.421)
γ-GTP A 1 1 1 1
B 4.832(2.129–10.964) 4.654(2.025–10.696) 3.669(1.562–8.618) 3.685(1.405–9.667)
R 3.060(1.413–6.628) 2.978(1.366–6.494) 2.021(0.888–4.598) 2.149(0.855–5.404)
IFG impaired fasting glucose, DM diabetes mellitus, AST aspartate aminotransferase, ALT alanine aminotransferase, γ-GTP gamma-glutamyltransferase
Model 1 adjusted for age, sex
Model 2 adjusted for age, sex, body mass index
Model 3 adjusted for age, sex, body mass index, AUDIT score, systolic blood pressure, triglyceride
Odds ratio and 95 % confidence interval by multiple logistic regression analysis
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related to features of insulin resistance as well as to high
plasma levels of insulin and glucose [27, 28].
Our study findings are also consistent with results of
studies on the relations between γ-GTP and the incidences
of IFG and type 2 DM [13, 29, 30], and also consistent with
a study showing that γ-GTP, as an index of oxidative stress,
was an independent risk factor of cerebro-cardiovascular
diseases [31]. Although the mechanism to explain the rela-
tionship of γ-GTP with DM was not fully elucidated, a
number of previous studies have proposed some hypoth-
eses as follows. First, serum γ-GTP is an index of insulin
resistance related to non-alcoholic fatty liver, and elevation
of serum γ-GTP is the result of obesity and deposition of
visceral fat [5, 32, 33]. Second, elevation of γ-GTP results
in chronic inflammation, which, in turn, inhibits insulin
metabolism in other organs as well as in the liver, and is in-
volved in the production of cytokines such as TNF-α and
IL-6 that are involved in fatty liver formation [34–36].
Third, increased γ-GTP concentration in the blood may be
a response to oxidative stress in the body, and oxidative
stress plays an important role in the mechanism of DM de-
velopment [7, 37].
As we analyzed the relationships between liver enzyme
levels and incidence of IFG or DM, we can see character-
istic results about borderline elevation of liver enzyme
levels. We categorized the levels of serum liver enzymes
into grades A (normal), B (borderline elevation), and R
(definite elevation), and found that the risks of IFG or DM
for all three liver enzymes were higher in the B group than
in the R group. Also, it was observed that borderline ele-
vation of ALT and γ-GTP was an independent risk factor
of development of IFG or DM, showing a significant result
after adjustment for other variables. There were several
study results concerning about dose-dependent relation-
ships between serum γ-GTP and IFG and DM. Most of
them showed a linear increase in the relation between γ-
GTP and IFG. A cross-sectional study on the prevalence
rates of DM and IFG depending on γ-GTP, on 8666
healthy Koreans, found that as γ-GTP increased, the risks
of DM and IFG also linearly increased [38]. Another
cross-sectional study involving about 29,959 healthy Ko-
reans who visited health checkup center, when γ-GTP
levels were divided into five groups within normal concen-
tration range, γ-GTP was shown to have strong linear cor-
relations with IFG and DM in both males and females
[39]. In a 4-year follow-up study with 4088 healthy male
workers, a normal range of γ-GTP showed a strong dose-
response relationship with DM incidence [11]. Results of
last two study suggested that an increase in γ-GTP con-
centration within its physiological range is a sensitive and
early biomarker for the development of diabetes which
consistent with our results.
There are two possible explanations for the reasons
why the borderline elevation of liver enzyme had higher
risk than definite elevation. First explanation is possibil-
ity of selective intervention only for R grade group. Since
this study was designed as a follow-up study, workers
who had determined to be R grade liver enzyme level in
the initial health checkup might had recognized their
own health conditions more seriously than workers with
B grade. Therefore, it was possible that they could have
been more active in exerting effort in managing their
health and changing health related life styles. In most
cases of workplace settings, active health intervention ef-
forts of occupational health managers were targeted only
for workers with R grade. Therefore, it was possible that
more active interventions were likely to be conducted
for those with R than B grade. It was assumed that this
selective interventions play a role to leading a relatively
lower risk of IFG or DM in the R than B group. Another
possible explanation is that borderline elevation of liver
enzymes could indicate a genuine higher risk of IFG or
DM than definite elevation. We should not conclusively
accept this assumption because we currently do not have
sufficient evidence to support this it. However, from the
point of view of prediction of future occurrence of IFG
or DM, we speculate that borderline elevation of liver
enzymes may indicate a higher risk than definite eleva-
tion; at the very least, the risk of IFG or DM is as high
as for a definite elevation. A high rise in liver enzyme
level could be usual expression of intrinsic liver path-
ology or index of heavy alcohol drinking rather than
early predictive index of cardiovascular diseases. As for a
index of cardiovascular risk factor in healthy young
workers, it could possible that liver enzyme tend to be
expressed as a mild elevation rather than severe eleva-
tion. Even though this assumption is lack of scientific
evidence, this issue should be investigated in future
more scientific research.
The limitations of the present study are as follows: First,
as this study was conducted only for healthy workers, and
the study sample was small, it is difficult to generalize the
study results to the entire working population. The DM
prevalence rate of this study was 2.4 % at initially, and that
of IFG was 13.1 %. In comparison with the 10.1 % DM
prevalence rate and 19.9 % IFG prevalence rate in Korea in
2010 [40], the prevalence rate of DM and IFG were rela-
tively lower, which is speculated to be because the workers
of this study were relatively younger workers who are in a
good health condition. Second, as only four workers were
found to have DM in the health checkup after 7 years, the
abnormal blood glucose group was defined together as IFG
or DM as a dependent variable. Third, because there were
many missing survey questions about disease history or
current health condition due to the nature of the self-
administered questionnaire, disease history (e.g., hepatitis B)
and medication history, family history of DM that could
serve as confounding variables could not be reflected
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accurately. In addition, although fasting insulin level and
waist circumference could serve as important confounding
variables, they were not evaluated. A few studies reported
that waist circumference is more useful than BMI in the
prediction of DM incidence [41, 42].
Despite of few limitations, as a 7 year follow-up study,
its follow-up rate was as high as 91.3 %, which demon-
strates that it was appropriately designed to investigate
the causal relationships between IFG or DM and serum
liver enzyme levels. Since, the ranges of serum liver en-
zymes were divided according to the standard of the
NHIS of Korea that is currently conducted on worker’s
health checkup, the obtained results could be directly
applicable to occupational health management. The re-
sults showing that borderline ALT or γ-GTP levels had a
three times higher risk of IFG or DM after 7 years than
normal workers, and that as the number of abnormal
liver enzymes increased the risk also increased, can be
directly used for the interpretation of health checkup re-
sults. Mild rise in liver enzyme in health checkup is
likely to be a warning sign of accumulation of unhealthy
life style, although young workers tend to ignore such
results. On the basis of the results of this study, workers
should be reminded that even a mild initial abnormality
in liver enzyme levels could lead to the occurrence of
chronic diseases such as IFG and DM in a few years.
Conclusion
In conclusion, our data showed that borderline elevations
of ALT and γ-GTP, but not AST, increased the incidence
rate and risks of IFG or DM after 7 years, and borderline
elevation of ALTand γ-GTP was an independent risk factor
for the incidence of IFG or DM. The results of this study
could be used as a basis for more active and detailed health
management and intervention measures for workers who
have borderline levels of serum liver enzymes in occupa-
tional health checkup results.
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